Abstract:Abstract BACKGROUND AND AIMS Cardiovascular disease (CVD) is the leading cause of death among patients with chronic kidney disease (CKD). In addition to diabetes, hypertension, dyslipidaemia and inflammation, vascular calcification and its severity have long been recognized as a major factor in the development of CVD in patients with CKD. CKD favours gut dysbiosis, and this dysbiosis may contribute to the aggravation of CVD, inflammation, and vascular calcification in CKD. Therefore, our aim was to study the potential interconnection between vascular calcification, mortality risk, and the gut microbiome in CKD patients on peritoneal dialysis (PD). METHOD A group of 44 CKD patients on PD was evaluated concerning major inflammatory markers and key players of CKD-mineral bone disorder. Vascular calcification severity was assessed by the Adragao score, and all-cause mortality risk was assessed using the Charlson comorbidity index. Gut microbiome profile was obtained by sequencing the V3–V4 region of 16S rRNA. RESULTS The global mean of the Adragao score of our CKD-PD patients was 2.98 ± 2.74, including 26.1% with no vascular calcification (Adragao score = 0), 30.4% with moderate vascular calcification (Adragao score of 1 or 2), and 39.1% presenting severe vascular calcification (Adragao score higher than 2). When comparing CKD-PD patients with moderate or severe vascular calcification with CKD-PD patients with no vascular calcification, we found statistically significant differences regarding age (47.7 ± 11.5 versus 59.4 ± 8.8; P < 0.01), sex (% male 33.3% versus 78.1%; P = 0.011), total Kt/V (urea) (2.6 ± 0.6 versus 2.1 ± 0.4; P = 0.04) and history of diabetes mellitus (8.3% versus 48.8%; P = 0.035). No differences were found regarding the expression of inflammation markers between the two groups. When vascular calcification severity was correlated with all-cause mortality risk scored by the Charlson comorbidity index, we observed a positive significant correlation between these two factors (Spearman correlation, correlation coefficient = 0.538; P < 0.001). When comparing PD patients with and without vascular calcification, no significant differences were found regarding gut microbiome profile. Nonetheless, relative changes of specific taxa were observed, namely regarding Coprobacter, Coprococcus 3, Lactobacillus and Eubacterium eligens group in the gut microbiome. Among these taxonomic differences, patients with different Charlson comorbidity index values also demonstrated changes in the Eubacterium eligens group in the gut microbiome. The Adragao score and the Charlson index were positively correlated. CONCLUSION There is an association between vascular calcification and mortality risk in CKD patients on PD. We have found small differences in some specific taxa when comparing the gut microbiomes of CKD-PD patients with and without vascular calcification. Future studies exploring the role of these bacterial groups in the increased risk of vascular calcification, mortality and CVD in CKD-PD patients are of extreme relevance to ensure the health and well-being of these patients.

Relationship between gut microbiota and vascular calcification in hemodialysis patients

Abdominal Aortic Calcification is Not Superior over Other Vascular Calcification in Predicting Mortality in Hemodialysis Patients: a Retrospective Observational Study

The Role of Extracellular Vesicles in Vascular Calcification in Chronic Kidney Disease

Vascular Calcification and the Gut and Blood Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Pilot Study

Higher serum trimethylamine-N-oxide levels are associated with increased abdominal aortic calcification in hemodialysis patients

MO737: Vascular Calcification and the Gut Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis

Cardiac valve calcification is associated with mortality in hemodialysis patients: a retrospective cohort study

Role of symbiotic microbiota dysbiosis in the progression of chronic kidney disease accompanied with vascular calcification

Role of Gut Microbiota-Derived Metabolites on Vascular Calcification in CKD

Elucidating the relationship between nutrition indices and coronary artery calcification in patients undergoing maintenance hemodialysis

Prognosis and risk factors for cardiac valve calcification in Chinese end-stage kidney disease patients on combination therapy with hemodialysis and hemodiafiltration

Heart valve calcification and calcium x phosphorus product in hemodialysis patients: Analysis of optimum values for its prevention

Association of plasma microRNA-16-5p and abdominal aortic calcification in maintenance hemodialysis patients

Prevalence and Risk Factors for Vascular Calcification in Chinese Patients Receiving Dialysis: Baseline Results from a Prospective Cohort Study

Aortic Artery and Cardiac Valve Calcification Are Associated with Mortality in Chinese Hemodialysis Patients: A 3.5 Years Follow-up.

Role of the gut microbiota and their metabolites in hemodialysis patients

Visceral Fat Area Is a Better Predictor Than Coronary Artery Calcification Score for Cardiovascular Outcomes and All-Cause Death in Patients on Hemodialysis

Progression of cardiovascular calcification in hemodialysis patients

Association of abdominal aortic calcification estimated by plain radiography with outcomes in haemodialysis patients: A 6-year follow-up study

YKL-40 (chitinase-3-like protein 1) serum levels are associated with abdominal aortic calcification in hemodialysis patients

Incidence of abdominal aortic calcification and its relationship with cardiovascular diseases in patients undergoing maintenance hemodialysis